Skip to main content

Surprising finding in the kidney

Apr. 16, 2015, 7:00 PM

by Barbara O’Brien

Progressive renal fibrosis is the common pathway whereby kidney injury of all causes leads to renal failure requiring dialysis or kidney transplantation. Thus, finding molecular targets for treatment of renal fibrosis is essential.

A major mediator of renal fibrosis is transforming growth factor-beta (TGF-beta) signaling. Interstitial cells that produce extracellular matrix are the cells thought to be responsible for TGF-beta-dependent fibrosis, making TGF-beta signaling in interstitial cells a potential target for reducing renal fibrosis.

However, fibrosis after renal injury was not reduced when the TGF-beta receptor was “knocked out” in interstitial cells in a mouse model, Leslie Gewin, M.D., and colleagues reported recently in the journal Kidney International. Blocking TGF-beta signaling in interstitial cells thus is not sufficient to reduce fibrosis, they concluded.

Clinical trials of TGF-beta inhibitors have been disappointing, implying that better understanding of how TGF-beta mediates response to injury and identification of additional components that contribute to fibrosis are critical for developing future therapeutic targets.

This research was supported by a Career Development Award from the Department of Veterans Affairs, by the Pediatric Nephrology Center of Excellence, VA Merit Awards and grants from the National Institutes of Health (DK051265, DK095785, DK083187, DK075594, DK069221).

Send suggestions for articles to highlight in Aliquots and any other feedback about the column to aliquots@vanderbilt.edu

Recent Stories from VUMC News and Communications Publications

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

Momentum

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

more